View printer-friendly version

Download PDF

Emergent BioSolutions to Participate in June and July 2013 Investor Conferences

ROCKVILLE, Md.–(BUSINESS WIRE)–Jun. 6, 2013– Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company’s senior management team will participate in the following investor conferences during June and July 2013:

• Wells Fargo Securities Research & Economics 2013 Healthcare Conference
  Boston, MA
  June 18-19, 2013

• Janney Capital Markets Boston Healthcare 1X1 Corporate Access Day
  Boston, MA
  June 27, 2013

• 8^th Annual JMP Securities Healthcare Conference
  New York, NY
  July 9-10, 2013

For the Janney Capital Markets conference, the company will only be participating in one-on-one meetings. The format of the conference does not include formal presentations.

For the Wells Fargo and JMP conferences, the company will be webcasting its formal presentations which will encompass a corporate overview and may include a discussion of the company’s recent business developments as well as its current financial results and financial guidance for the current year and latest quarterly period. The webcasts will be available both live and by replay, accessible from the Emergent website www.emergentbiosolutions.com under “Investors.”

About Emergent BioSolutions Inc.

Emergent BioSolutions is a specialty pharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Additional information about us may be found at www.emergentbiosolutions.com.

Follow us on Twitter: @emergentbiosolu.

Source: Emergent BioSolutions Inc.